Consolidated Statements of Changes in Stockholders' Equity (unaudited) - USD ($) $ in Thousands	Total	Revision of Prior Period, Accounting Standards Update, Adjustment	[1]	Common Stock	Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Balance at beginning of period (in shares) at Dec. 31, 2021				13,673,898
Balance at beginning of period at Dec. 31, 2021	$ 217,707			$ 13,674	$ 111,021	$ 99,189	$ (6,177)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)	(48,746)						(48,746)
Dividends on common shares	(3,365)					(3,365)
Issuance of common stock (in shares)				3,848,485
Issuance of common stock	59,468			$ 3,848	55,620
Issuance of restricted stock, net of forfeitures (in shares)				61,950
Issuance of restricted stock, net of forfeitures	0			$ 62	(62)
Tax withholding related to vesting of restricted stock (in shares)				(3,121)
Tax withholding related to vesting of restricted stock	(51)			$ (3)	(48)
Stock-based compensation expense	845				845
Net income	8,737					8,737
Balance at end of period (in shares) at Jun. 30, 2022				17,581,212
Balance at end of period at Jun. 30, 2022	$ 234,595			$ 17,581	167,376	104,561	(54,923)
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2016-13 [Member]
Balance at beginning of period (in shares) at Dec. 31, 2021				13,673,898
Balance at beginning of period at Dec. 31, 2021	$ 217,707			$ 13,674	111,021	99,189	(6,177)
Balance at end of period (in shares) at Dec. 31, 2022	17,598,123			17,598,123
Balance at end of period at Dec. 31, 2022	$ 230,268	$ (1,198)		$ 17,598	167,537	111,573	(66,440)
Balance at beginning of period (in shares) at Mar. 31, 2022				17,586,333
Balance at beginning of period at Mar. 31, 2022	250,277			$ 17,586	166,859	103,036	(37,204)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)	(17,719)						(17,719)
Dividends on common shares	(1,890)					(1,890)
Issuance of restricted stock, net of forfeitures (in shares)				(2,000)
Issuance of restricted stock, net of forfeitures	0			$ (2)	2
Tax withholding related to vesting of restricted stock (in shares)				(3,121)
Tax withholding related to vesting of restricted stock	(51)			$ (3)	(48)
Stock-based compensation expense	563				563
Net income	3,415					3,415
Balance at end of period (in shares) at Jun. 30, 2022				17,581,212
Balance at end of period at Jun. 30, 2022	$ 234,595			$ 17,581	167,376	104,561	(54,923)
Balance at beginning of period (in shares) at Dec. 31, 2022	17,598,123			17,598,123
Balance at beginning of period at Dec. 31, 2022	$ 230,268	$ (1,198)		$ 17,598	167,537	111,573	(66,440)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)	3,525						3,525
Dividends on common shares	(3,863)					(3,863)
Issuance of restricted stock, net of forfeitures (in shares)				(8,671)
Issuance of restricted stock, net of forfeitures	0			$ (9)	9
Tax withholding related to vesting of restricted stock (in shares)				(6,310)
Tax withholding related to vesting of restricted stock	(78)			$ (6)	(72)
Repurchase of shares (in shares)				(41,481)
Repurchase of shares	(406)			$ (41)	(365)
Stock-based compensation expense	862				862
Net income	$ 10,345					10,345
Balance at end of period (in shares) at Jun. 30, 2023	17,541,661			17,541,661
Balance at end of period at Jun. 30, 2023	$ 239,455			$ 17,542	167,971	116,857	(62,915)
Balance at beginning of period (in shares) at Mar. 31, 2023				17,593,879
Balance at beginning of period at Mar. 31, 2023	238,777			$ 17,594	167,922	113,485	(60,224)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other comprehensive income (loss)	(2,691)						(2,691)
Dividends on common shares	(1,930)					(1,930)
Issuance of restricted stock, net of forfeitures (in shares)				(10,217)
Issuance of restricted stock, net of forfeitures	0			$ (10)	10
Tax withholding related to vesting of restricted stock (in shares)				(520)
Tax withholding related to vesting of restricted stock	(5)			$ (1)	(4)
Repurchase of shares (in shares)				(41,481)
Repurchase of shares	(406)			$ (41)	(365)
Stock-based compensation expense	408				408
Net income	$ 5,302					5,302
Balance at end of period (in shares) at Jun. 30, 2023	17,541,661			17,541,661
Balance at end of period at Jun. 30, 2023	$ 239,455			$ 17,542	$ 167,971	$ 116,857	$ (62,915)

[1]  (1) Represents the impact of the adoption of Accounting Standards Update ("ASU") No. 2016-13: CECL